Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease - Concepedia

Concepedia

Publication | Open Access

Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease

DOI Full Paper Access

26

Citations

48

References

2023

Year

Mayuko Chikamatsu, Hiroshi Watanabe, Yuhi Shintani, Ryota Murata, Masako Miyahisa, Ayano Nishinoiri, Tadashi Imafuku, Mei Takano, Nanaka Arimura, Koh‐ichi Yamada,

Journal of Controlled Release

Metabolic SyndromeMetabolic Associated SteatohepatitisHepatologyNonalcoholic Fatty Liver DiseaseMedicineLiver PhysiologyPathologyFibroblast Growth FactorLiver DiseaseFatty Liver DiseaseLiverPharmacologyDrug-induced Liver InjuryHealth Sciences

References

	Year	Citations

Page 1

Page 1